XML 23 R12.htm IDEA: XBRL DOCUMENT v3.24.3
Research and Development Costs
9 Months Ended
Sep. 30, 2024
Research and Development [Abstract]  
Research and Development Costs

3. Research and Development Costs

 

A summary of research and development costs for the three months and nine months ended September 30, 2024 and 2023, including costs associated with clinical trials involving the Company’s lead clinical compound LB-100, are summarized below based on the respective geographical regions where such costs have been incurred.

Schedule of Research and Development Costs 

   2024   2023   2024   2023 
  

Three Months Ended

September 30,

  

Nine Months Ended

September 30,

 
   2024   2023   2024   2023 
                 
United States  $278,808   $68,315   $427,736   $291,846 
Spain   6,544    9,496    51,022    283,035 
China       3,108    2,282    17,198 
Netherlands   76,278    51,568    210,362    156,950 
Total  $361,630   $132,487   $691,402   $749,029